William Blair discusses their recent initiation of coverage for Moderna (MRNA-Market Perform), AbbVie (ABBV-Market Perform) and Arcturus (ARCT-Outperform), as well as key considerations and risks to investment theses for these companies on July 28 at 11:30 am. Webcast Link
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on MRNA:
- William Blair to hold a webinar on initiation of coverage
- Merck, Moderna initiate Phase 3 study of V940 in combination with Keytruda
- Tesla downgraded, Netflix upgraded: Wall Street’s top analyst calls
- Moderna price target lowered to $165 from $175 at TD Cowen
- Moderna initiated with a Market Perform at William Blair
Questions or Comments about the article? Write to editor@tipranks.com